| Literature DB >> 15657609 |
Susanne Kohl1, Balazs Varsanyi, Gesine Abadin Antunes, Britta Baumann, Carel B Hoyng, Herbert Jägle, Thomas Rosenberg, Ulrich Kellner, Birgit Lorenz, Roberto Salati, Bernhard Jurklies, Agnes Farkas, Sten Andreasson, Richard G Weleber, Samuel G Jacobson, Günther Rudolph, Claudio Castellan, Helene Dollfus, Eric Legius, Mario Anastasi, Pierre Bitoun, Dorit Lev, Paul A Sieving, Francis L Munier, Eberhart Zrenner, Lindsay T Sharpe, Frans P M Cremers, Bernd Wissinger.
Abstract
Achromatopsia is a congenital, autosomal recessively inherited disorder characterized by a lack of color discrimination, low visual acuity (<0.2), photophobia, and nystagmus. Mutations in the genes for CNGA3, CNGB3, and GNAT2 have been associated with this disorder. Here, we analyzed the spectrum and prevalence of CNGB3 gene mutations in a cohort of 341 independent patients with achromatopsia. In 163 patients, CNGB3 mutations could be identified. A total of 105 achromats carried apparent homozygous mutations, 44 were compound (double) heterozygotes, and 14 patients had only a single mutant allele. The derived CNGB3 mutation spectrum comprises 28 different mutations including 12 nonsense mutations, eight insertions and/or deletions, five putative splice site mutations, and three missense mutations. Thus, the majority of mutations in the CNGB3 gene result in significantly altered and/or truncated polypeptides. Several mutations were found recurrently, in particular a 1 bp deletion, c.1148delC, which accounts for over 70% of all CNGB3 mutant alleles. In conclusion, mutations in the CNGB3 gene are responsible for approximately 50% of all patients with achromatopsia. This indicates that the CNGB3/ACHM3 locus on chromosome 8q21 is the major locus for achromatopsia in patients of European origin or descent.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15657609 DOI: 10.1038/sj.ejhg.5201269
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246